ECSP099726A - Anticuerpos contra la il-25 - Google Patents
Anticuerpos contra la il-25Info
- Publication number
- ECSP099726A ECSP099726A EC2009009726A ECSP099726A ECSP099726A EC SP099726 A ECSP099726 A EC SP099726A EC 2009009726 A EC2009009726 A EC 2009009726A EC SP099726 A ECSP099726 A EC SP099726A EC SP099726 A ECSP099726 A EC SP099726A
- Authority
- EC
- Ecuador
- Prior art keywords
- antibodies against
- antibody
- therapy
- useful
- provides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención proporciona el anticuerpo 2C3 y miembros de unión a diana basados en 2C3 que se unen a la interleuquina-25. Éstos son útiles en terapia.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0707505.4A GB0707505D0 (en) | 2007-04-18 | 2007-04-18 | Antibodies against il-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP099726A true ECSP099726A (es) | 2010-01-29 |
Family
ID=38135020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2009009726A ECSP099726A (es) | 2007-04-18 | 2009-11-10 | Anticuerpos contra la il-25 |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US8206717B2 (es) |
| EP (1) | EP2144934B1 (es) |
| JP (1) | JP5366930B2 (es) |
| KR (1) | KR101605861B1 (es) |
| CN (1) | CN101711256B (es) |
| AU (1) | AU2008240436B2 (es) |
| BR (1) | BRPI0810418A8 (es) |
| CA (1) | CA2684492C (es) |
| CO (1) | CO6260104A2 (es) |
| CR (1) | CR11079A (es) |
| CY (1) | CY1118244T1 (es) |
| DK (1) | DK2144934T3 (es) |
| EA (1) | EA018073B1 (es) |
| EC (1) | ECSP099726A (es) |
| ES (1) | ES2604255T3 (es) |
| GB (1) | GB0707505D0 (es) |
| GT (1) | GT200900271A (es) |
| HN (1) | HN2009003038A (es) |
| HR (1) | HRP20161548T1 (es) |
| HU (1) | HUE030935T2 (es) |
| IL (1) | IL201552A (es) |
| LT (1) | LT2144934T (es) |
| MX (1) | MX2009011234A (es) |
| MY (1) | MY148451A (es) |
| NI (1) | NI200900189A (es) |
| NZ (1) | NZ581178A (es) |
| PL (1) | PL2144934T3 (es) |
| PT (1) | PT2144934T (es) |
| RS (1) | RS55401B1 (es) |
| SI (1) | SI2144934T1 (es) |
| UA (1) | UA100377C2 (es) |
| WO (1) | WO2008129263A1 (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0817891D0 (en) | 2008-09-30 | 2008-11-05 | Medical Res Council | Antibodies against il-25 |
| US8574582B2 (en) * | 2008-10-31 | 2013-11-05 | Janssen Biotech, Inc. | Methods for mediating fibrotic response |
| GB0905972D0 (en) | 2009-04-06 | 2009-05-20 | Medical Res Council | Antibodies against IL-17BR |
| AU2010291985B2 (en) | 2009-09-14 | 2016-05-05 | The Regents Of The University Of Colorado | Modulation of yeast-based immunotherapy products and responses |
| LT2552961T (lt) | 2010-03-30 | 2018-02-12 | Janssen Biotech, Inc. | Humanizuoti il-25 antikūnai |
| US9546219B2 (en) | 2012-02-08 | 2017-01-17 | North Carolina State University | Treatment of allergic diseases with recombinant antibodies |
| JP6250351B2 (ja) * | 2013-09-30 | 2017-12-20 | シスメックス株式会社 | 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー |
| CN103792375B (zh) * | 2014-01-29 | 2017-07-07 | 华中科技大学同济医学院附属同济医院 | 外周血白细胞介素25水平在哮喘分型中的应用及分型方法 |
| WO2016049000A2 (en) * | 2014-09-23 | 2016-03-31 | Regeneron Pharmaceuticals, Inc. | Anti-il-25 antibodies and uses thereof |
| WO2017160587A1 (en) | 2016-03-16 | 2017-09-21 | Abeome Corporation | Neutralizing monoclonal antibodies to il-25 and uses thereof |
| WO2018017864A2 (en) * | 2016-07-20 | 2018-01-25 | Oncomed Pharmaceuticals, Inc. | Pvrig-binding agents and uses thereof |
| WO2018018082A1 (en) | 2016-07-26 | 2018-02-01 | The Australian National University | Immunostimulatory compositions and uses therefor |
| EP3538558A4 (en) | 2016-11-09 | 2020-07-15 | North Carolina State University | TREATMENT OF ALLERGIC DISEASES USING CHIMERIC PROTEIN |
| US12060437B2 (en) | 2018-03-23 | 2024-08-13 | North Carolina State University | Methods and compositions for antibody to high affinity receptor for IgE |
| WO2020102935A1 (en) * | 2018-11-19 | 2020-05-28 | Suzhou Kanova Biopharmaceutical Co., Ltd. | Anti-il-25 antibodies and use thereof |
| GB202018015D0 (en) | 2020-11-16 | 2020-12-30 | Res & Innovation Uk | Composition and methods for the treatment of intestinal cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6569645B2 (en) | 1999-05-14 | 2003-05-27 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| CN1289668C (zh) * | 2003-06-12 | 2006-12-13 | 北京安波特基因工程技术有限公司 | 一种用于抗体改形的体外分子定向进化方法 |
| WO2006094384A1 (en) | 2005-03-08 | 2006-09-14 | Genesense Technologies Inc. | Use of interleukin 17e for the treatment of cancer |
| WO2007044450A2 (en) | 2005-10-06 | 2007-04-19 | Baylor Research Institute | Compositions and methods for the treatment of cancer |
| GB0817891D0 (en) | 2008-09-30 | 2008-11-05 | Medical Res Council | Antibodies against il-25 |
-
2007
- 2007-04-18 GB GBGB0707505.4A patent/GB0707505D0/en not_active Ceased
-
2008
- 2008-04-17 CN CN2008800206204A patent/CN101711256B/zh not_active Expired - Fee Related
- 2008-04-17 UA UAA200911796A patent/UA100377C2/ru unknown
- 2008-04-17 AU AU2008240436A patent/AU2008240436B2/en not_active Ceased
- 2008-04-17 WO PCT/GB2008/001365 patent/WO2008129263A1/en not_active Ceased
- 2008-04-17 HR HRP20161548TT patent/HRP20161548T1/hr unknown
- 2008-04-17 RS RS20161009A patent/RS55401B1/sr unknown
- 2008-04-17 PL PL08737025T patent/PL2144934T3/pl unknown
- 2008-04-17 EP EP08737025.0A patent/EP2144934B1/en active Active
- 2008-04-17 ES ES08737025.0T patent/ES2604255T3/es active Active
- 2008-04-17 LT LTEP08737025.0T patent/LT2144934T/lt unknown
- 2008-04-17 MY MYPI20094358A patent/MY148451A/en unknown
- 2008-04-17 US US12/596,053 patent/US8206717B2/en active Active
- 2008-04-17 JP JP2010503589A patent/JP5366930B2/ja not_active Expired - Fee Related
- 2008-04-17 MX MX2009011234A patent/MX2009011234A/es active IP Right Grant
- 2008-04-17 EA EA200901421A patent/EA018073B1/ru not_active IP Right Cessation
- 2008-04-17 CA CA2684492A patent/CA2684492C/en not_active Expired - Fee Related
- 2008-04-17 HU HUE08737025A patent/HUE030935T2/en unknown
- 2008-04-17 NZ NZ581178A patent/NZ581178A/en not_active IP Right Cessation
- 2008-04-17 SI SI200831698A patent/SI2144934T1/sl unknown
- 2008-04-17 PT PT87370250T patent/PT2144934T/pt unknown
- 2008-04-17 DK DK08737025.0T patent/DK2144934T3/en active
- 2008-04-17 KR KR1020097023939A patent/KR101605861B1/ko not_active Expired - Fee Related
- 2008-04-17 BR BRPI0810418A patent/BRPI0810418A8/pt not_active Application Discontinuation
-
2009
- 2009-10-15 IL IL201552A patent/IL201552A/en active IP Right Grant
- 2009-10-16 NI NI200900189A patent/NI200900189A/es unknown
- 2009-10-16 GT GT200900271A patent/GT200900271A/es unknown
- 2009-10-16 HN HN2009003038A patent/HN2009003038A/es unknown
- 2009-10-28 CR CR11079A patent/CR11079A/es unknown
- 2009-11-03 CO CO09123670A patent/CO6260104A2/es active IP Right Grant
- 2009-11-10 EC EC2009009726A patent/ECSP099726A/es unknown
-
2016
- 2016-11-17 CY CY20161101187T patent/CY1118244T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI200900189A (es) | Anticuerpos contra la il-25 | |
| NZ767596A (en) | Antibodies that bind cd39 and uses thereof | |
| CY1117827T1 (el) | Anti-ifnar1 αντισωματα me μειωμενη συγγενεια προσδετη fc | |
| CR20120210A (es) | Proteínas de enlace al antigeno il-23 humanas | |
| CO2018011364A2 (es) | Anticuerpos anti-il-33, composiciones, métodos y usos de los mismos | |
| CR20140585A (es) | Proteinas de union a antigeno st2 | |
| CR20110559A (es) | Anticuerpos específicos para cadherina-17 | |
| UY37083A (es) | Anticuerpos anti-ror1, anticuerpos biespecíficos ror1 x cd3 y métodos para su uso | |
| MX2022006461A (es) | Anticuerpos anti-axl, fragmentos de anticuerpos y sus inmunoconjugados y usos de los mismos. | |
| PT3337824T (pt) | Anticorpos anti-bcma, moléculas de ligação a antigénio biespecíficas que ligam bcma e cd3, e suas utilizações | |
| EA201390146A1 (ru) | Антитела к матриксной металлопротеиназе 9 | |
| CY1116261T1 (el) | Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων | |
| CY2016030I1 (el) | Αντισωματα εναντι της il-17 | |
| PL3181581T3 (pl) | Przeciwciała o zmodyfikowanym powinowactwie do FcRn, które wspomagają klierens antygenu | |
| CY1121167T1 (el) | Βελτιωμενα αντισωματα εναντι της ανθρωπινης φρακταλκινης και χρησεις αυτων | |
| PL2195017T3 (pl) | Ludzkie antyciała, które wiążą mezotelinę i ich zastosowania | |
| BR112012013876A2 (pt) | proteínas de ligação do antígeno humano que ligam o seu b-klotho, receptores de fgf e seus complexos | |
| BR112017002646A2 (pt) | proteínas de fusão da imunoglobulina sirp-alfa | |
| UA106070C2 (uk) | Антитіло, що специфічно зв'язується з egfr і her3 | |
| TR201821029T4 (tr) | Geliştirilmiş antı-IL-23p19 antikorları. | |
| EP2544540A4 (en) | LENALIDOMIDE AND THALIDOMIDE IMMUNASSAYS | |
| MX377297B (es) | Anticuerpos tem8 y su uso. | |
| ES2684475T3 (es) | Proteínas que se unen a beta amiloide | |
| BR112014012590A8 (pt) | Anticorpos anti-cd98 e métodos de uso dos mesmos | |
| NZ602220A (en) | Antibodies with ph dependent antigen binding |